Back to Trades
Dorton Katina
DirectorCIK 0001617541
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 9
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 4
- Active
- 2025–2026
Across 9 filings between 2025–2026, Dorton Katina, Director, has disclosed $333.5K in transactions — spread across 4 companies. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
9 loaded
| Jul 17 | NONE Keenova Therapeutics plc | Dorton Katina | Director | Award | $0 |
| Jul 2 | FULC Fulcrum Therapeutics, Inc. | Dorton Katina | Insider | Award | $117.1K |
| Jun 10 | PRLD Prelude Therapeutics Inc | Dorton Katina | Insider | Award | $149.7K |
| Jun 4 | NONE Keenova Therapeutics plc | Dorton Katina | Director | Exercise | $0 |
| May 22 | TCRX TScan Therapeutics, Inc. | Dorton Katina | Insider | Award | $66.6K |
| Feb 25 | NONE Keenova Therapeutics plc | Dorton Katina | Director | Award | $0 |
| Jan 5 | NONE Keenova Therapeutics plc | Dorton Katina | Director | Exercise | $0 |
| Aug 18 | NONE Mallinckrodt plc | Dorton Katina | Director | Award | $0 |
| Aug 4 | NONE Mallinckrodt plc | Dorton Katina | Director | Award | $0 |
9 filings